Medical Doctor Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Jeffrey Shy

Neurology Mesa, AZ Medical Doctor

NPI 1831246503 CMS profile 218786

4216 N Ranier, Suite 110, Mesa, AZ 85215

Open in the dashboard

General payments

$5,902

350 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$47,296 paid to institutions, not to them · program years 2019–2021

Through program year 2021, Jeffrey Shy of Mesa, AZ is reported in the CMS Open Payments database as having received $5,902 across 350 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $47,296 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 68th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $3,060 170
2020 General $2,640 169
2019 General $202 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Shy
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Jeffrey Shy were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Jeffrey Shy Neurology median Middle half National median
2019 $202 $474 $118–$2,177 $163
2020 $2,640 $367 $82–$2,309 $114
2021 $3,060 $438 $104–$2,547 $132
2022 $0 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Amgen Inc. $680 34 payments
  2. Allergan Inc. $592 32 payments
  3. Biogen, Inc. $419 34 payments
  4. AbbVie, Inc. $343 20 payments
  5. UCB, Inc. $337 25 payments
  6. Upsher-Smith Laboratories LLC $265 20 payments
  7. Supernus Pharmaceuticals, Inc. $233 28 payments
  8. CSL Behring $224 10 payments
  9. Sunovion Pharmaceuticals Inc. $218 13 payments
  10. Lilly USA, LLC $189 13 payments
  11. Other $2,402 121 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Food and Beverage $5,791 341 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $71 4 payments
  3. Education $40 5 payments
Products named General payments · program years 2019–2021
  1. AIMOVIG $680 34 payments
  2. BOTOX $460 21 payments
  3. VUMERITY $272 25 payments
  4. TROKENDI XR $233 28 payments
  5. Hizentra $224 10 payments
  6. Neupro $212 16 payments
  7. DUOPA $211 9 payments
  8. REYVOW $189 13 payments
  9. APTIOM $189 9 payments
  10. Zembrace SymTouch Sumatriptan Injection $182 15 payments
  11. Other $3,744 203 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

350 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record